Thus, to further elucidate the potential impact of ARPC5 on the tumor immunity, we first applied the ESTIMATE algorithm to assess Immune and Stromal scores for 33 cancer types and analyzed the association between ARPC5 expression and Immune/Stromal scores using Spearman’s correlation method. The gene discussed is ARPC5; the disease is neoplasm.